Viewing Study NCT02124902


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-01-29 @ 4:41 AM
Study NCT ID: NCT02124902
Status: TERMINATED
Last Update Posted: 2022-11-07
First Post: 2014-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
Sponsor: Washington University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 201404107
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None NIH View
None OTHER View
None INDUSTRY View